Johnson & Johnson, Global Diabetes Institute

October 16, 2007– Johnson & Johnson (NYSE: JNJ) announced the establishment of the Johnson & Johnson Diabetes Institute (JJDI) to transform diabetes care by providing comprehensive training on the latest practice standards, new diabetes tools and technologies and reimbursement solutions to physicians, nurses, physician assistants and diabetes educators around the globe... Johnson & Johnson's Press Release -